Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

Background : High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types. However, there has been little study of the role of TMB-H in advanced biliary tract cancer (BTC). Methods : We analyzed 119 advanced BTC patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hongsik Kim MD, Hana Kim MD, Ryul Kim MD, PhD, Hyunji Jo MD, Hye Ryeon Kim MD, Joohyun Hong MD, PhD, Joon Oh Park MD, PhD, Young Suk Park MD, PhD, Seung Tae Kim MD, PhD
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/83fd42d3d7f54068817202539c732b95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!